💡 50% of hires happen without a job posting·⚡ Apply spontaneously to dozens of companies📈 Track opens & CV clicks
Bioxodes
Public profile- , Belgium
- 1-10 collaborators
- Pharmaceutical/Biotech
- and 1 others
- , Belgium
- 1-10 collaborators
- Pharmaceutical/Biotech
- and 1 others
Overview Bioxodes
http://www.bioxodes.comAbout us
What we do: Bioxodes is a clinical-stage biopharmaceutical company focused on discovering and developing first-in-class therapies for thrombotic and inflammatory diseases. Its lead product candidate, BIOX-101, is derived from a protein found in tick saliva and aims to reduce the secondary neuroinflammatory effects of hemorrhagic stroke, specifically intracerebral hemorrhage (ICH), a condition with no approved treatments. The company also develops a pipeline targeting chronic thrombo-inflammatory and inflammatory diseases by modulating neutrophil activation and NETs formation.
Where we are located: Bioxodes is headquartered at Rue Santos-Dumont 1, 6041 Charleroi, Belgium, with operations based in Gosselies, Belgium.
Short history: Founded in 2013, Bioxodes has steadily advanced its clinical programs, securing significant funding rounds including a €2.7 million Series A extension in 2025. The company has achieved Orphan Drug Designation for BIOX-101 in Europe and the U.S. and is preparing for a potentially registrational Phase 2b clinical trial for ICH.
Organization & culture: Bioxodes employs a dynamic team of approximately 14 people. The company culture emphasizes scientific excellence, integrity, and collaboration, fostering an environment where diverse expertise from cellular biology to project management contributes to innovative therapeutic development. The team is committed to advancing healthcare and improving patient outcomes through cutting-edge research.
Recent developments: In early 2025, Bioxodes secured additional funding to complete its Phase 2a BIRCH trial and prepare for the Phase 2b trial of BIOX-101. Interim data from the BIRCH trial and decisions regarding Orphan Drug Designation are anticipated milestones. The company is also strengthening its top management and pursuing Series B financing.
Company roles mapping
This mapping combines roles declared by the company and roles identified by artificial intelligence from public data or past job offers. Some job titles are also standardised according to the European ESCO nomenclature (European Skills, Competences, Qualifications and Occupations) to ensure consistency with European skills frameworks. Learn more about AI transparency and ESCO →
- Business Development Manager
- Sales Manager
- Key Account Manager
- Customer Success Manager
- Sales Operations Manager
- Marketing Coordinator
- Digital Marketing Specialist
- Content Marketing Manager
- Social Media Manager
- HR Generalist
- Recruiter
- HR Manager
- Office Manager
- Purchase Manager
- Executive Assistant
- Communications Specialist
- Public Relations Specialist
- Social Media Specialist
Employee distribution by work field
Estimate based on public data and company information. Learn more about AI transparency →
